Bactiguard Holding AB
STO:BACTI B
Relative Value
The Relative Value of one
BACTI B
stock under the Base Case scenario is
26.53
SEK.
Compared to the current market price of 16.75 SEK,
Bactiguard Holding AB
is
Undervalued by 37%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BACTI B Competitors Multiples
Bactiguard Holding AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Bactiguard Holding AB
STO:BACTI B
|
519.9m SEK | 2.3 | -66.3 | -187.8 | -187.8 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.4B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.5T JPY | 10.4 | 38 | 27.5 | 33 | |
| CH |
|
Alcon AG
SIX:ALC
|
32.3B CHF | 4.1 | 39.9 | 16.6 | 32.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
109.3B DKK | 3.9 | 27.6 | 14.3 | 17 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.6B USD | 3.4 | 33.2 | 17.7 | 22.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.9B GBP | 2.7 | 38 | 15 | 25.6 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD | 1.2 | -17.6 | 18.1 | 58.5 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.3B CNY | 9.1 | 25 | 22.6 | 22.6 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
887B JPY | 6.8 | 50.1 | 23.7 | 32.2 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
3.8B CHF | 4.8 | 19.5 | 12.6 | 17.1 |